1. Home
  2. ALUR vs CASI Comparison

ALUR vs CASI Comparison

Compare ALUR & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • CASI
  • Stock Information
  • Founded
  • ALUR 2009
  • CASI 1991
  • Country
  • ALUR United States
  • CASI China
  • Employees
  • ALUR N/A
  • CASI N/A
  • Industry
  • ALUR
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALUR
  • CASI Health Care
  • Exchange
  • ALUR Nasdaq
  • CASI Nasdaq
  • Market Cap
  • ALUR 18.0M
  • CASI 20.5M
  • IPO Year
  • ALUR N/A
  • CASI 1996
  • Fundamental
  • Price
  • ALUR $3.02
  • CASI $1.48
  • Analyst Decision
  • ALUR Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • ALUR 3
  • CASI 1
  • Target Price
  • ALUR $22.83
  • CASI $4.00
  • AVG Volume (30 Days)
  • ALUR 213.4K
  • CASI 80.5K
  • Earning Date
  • ALUR 08-12-2025
  • CASI 08-15-2025
  • Dividend Yield
  • ALUR N/A
  • CASI N/A
  • EPS Growth
  • ALUR N/A
  • CASI N/A
  • EPS
  • ALUR N/A
  • CASI N/A
  • Revenue
  • ALUR $28,304,000.00
  • CASI $31,368,000.00
  • Revenue This Year
  • ALUR N/A
  • CASI N/A
  • Revenue Next Year
  • ALUR $49.37
  • CASI N/A
  • P/E Ratio
  • ALUR N/A
  • CASI N/A
  • Revenue Growth
  • ALUR N/A
  • CASI 8.39
  • 52 Week Low
  • ALUR $2.15
  • CASI $1.09
  • 52 Week High
  • ALUR $22.63
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 55.72
  • CASI 54.85
  • Support Level
  • ALUR $3.05
  • CASI $1.21
  • Resistance Level
  • ALUR $3.33
  • CASI $1.44
  • Average True Range (ATR)
  • ALUR 0.23
  • CASI 0.11
  • MACD
  • ALUR 0.02
  • CASI 0.03
  • Stochastic Oscillator
  • ALUR 63.49
  • CASI 72.97

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: